BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18467088)

  • 1. Inactivation by UDP-glucuronosyltransferase enzymes: the end of androgen signaling.
    Chouinard S; Yueh MF; Tukey RH; Giton F; Fiet J; Pelletier G; Barbier O; Bélanger A
    J Steroid Biochem Mol Biol; 2008 Apr; 109(3-5):247-53. PubMed ID: 18467088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of androgens by UDP-glucuronosyltransferases in the human prostate.
    Barbier O; Bélanger A
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):259-70. PubMed ID: 18471784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells.
    Chouinard S; Barbier O; Bélanger A
    J Biol Chem; 2007 Nov; 282(46):33466-33474. PubMed ID: 17848572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans.
    Bélanger A; Pelletier G; Labrie F; Barbier O; Chouinard S
    Trends Endocrinol Metab; 2003 Dec; 14(10):473-9. PubMed ID: 14643063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues.
    Bélanger A; Hum DW; Beaulieu M; Lévesque E; Guillemette C; Tchernof A; Bélanger G; Turgeon D; Dubois S
    J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):301-10. PubMed ID: 9699884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple roles for UDP-glucuronosyltransferase (UGT)2B15 and UGT2B17 enzymes in androgen metabolism and prostate cancer evolution.
    Gauthier-Landry L; Bélanger A; Barbier O
    J Steroid Biochem Mol Biol; 2015 Jan; 145():187-92. PubMed ID: 24861263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members.
    Turgeon D; Carrier JS; Lévesque E; Hum DW; Bélanger A
    Endocrinology; 2001 Feb; 142(2):778-87. PubMed ID: 11159850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium.
    Chouinard S; Pelletier G; Bélanger A; Barbier O
    Endocr Res; 2004 Nov; 30(4):717-25. PubMed ID: 15666817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoform-specific regulation of uridine diphosphate-glucuronosyltransferase 2B enzymes in the human prostate: differential consequences for androgen and bioactive lipid inactivation.
    Chouinard S; Pelletier G; Bélanger A; Barbier O
    Endocrinology; 2006 Nov; 147(11):5431-42. PubMed ID: 16887906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men.
    Swanson C; Mellström D; Lorentzon M; Vandenput L; Jakobsson J; Rane A; Karlsson M; Ljunggren O; Smith U; Eriksson AL; Bélanger A; Labrie F; Ohlsson C
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4878-82. PubMed ID: 17698910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The androgen-conjugating uridine diphosphoglucuronosyltransferase-2B enzymes are differentially expressed temporally and spatially in the monkey follicle throughout the menstrual cycle.
    Barbier O; Girard C; Berger L; El Alfy M; Bélanger A; Hum DW
    Endocrinology; 2001 Jun; 142(6):2499-507. PubMed ID: 11356699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular localization of uridine diphosphoglucuronosyltransferase 2B enzymes in the human prostate by in situ hybridization and immunohistochemistry.
    Barbier O; Lapointe H; El Alfy M; Hum DW; Bélanger A
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4819-26. PubMed ID: 11134149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes.
    Bao BY; Chuang BF; Wang Q; Sartor O; Balk SP; Brown M; Kantoff PW; Lee GS
    Prostate; 2008 Jun; 68(8):839-48. PubMed ID: 18302198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and characterization of a simian UDP-glucuronosyltransferase enzyme UGT2B20, a novel C19 steroid-conjugating protein.
    Barbier O; Bélanger A; Hum DW
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):567-74. PubMed ID: 9895303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen regulation of the glucuronidation enzyme UGT2B15 in estrogen receptor-positive breast cancer cells.
    Harrington WR; Sengupta S; Katzenellenbogen BS
    Endocrinology; 2006 Aug; 147(8):3843-50. PubMed ID: 16690804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitrol (1alpha,25-dihydroxyvitamin D3) inhibits androgen glucuronidation in prostate cancer cells.
    Kaeding J; Bélanger J; Caron P; Verreault M; Bélanger A; Barbier O
    Mol Cancer Ther; 2008 Feb; 7(2):380-90. PubMed ID: 18281521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of steroid glucuronosyltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line.
    Guillemette C; Hum DW; Bélanger A
    Endocrinology; 1996 Jul; 137(7):2872-9. PubMed ID: 8770908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of a simian UDP-glucuronosyltransferase UGT2B18 active on 3-hydroxyandrogens.
    Beaulieu M; Lévesque E; Barbier O; Turgeon D; Bélanger G; Hum DW; Bélanger A
    J Mol Biol; 1998 Feb; 275(5):785-94. PubMed ID: 9480769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications.
    Grosse L; Pâquet S; Caron P; Fazli L; Rennie PS; Bélanger A; Barbier O
    Cancer Res; 2013 Dec; 73(23):6963-71. PubMed ID: 24121496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel polymorphism in a forkhead box A1 (FOXA1) binding site of the human UDP glucuronosyltransferase 2B17 gene modulates promoter activity and is associated with altered levels of circulating androstane-3α,17β-diol glucuronide.
    Hu DG; Gardner-Stephen D; Severi G; Gregory PA; Treloar J; Giles GG; English DR; Hopper JL; Tilley WD; Mackenzie PI
    Mol Pharmacol; 2010 Oct; 78(4):714-22. PubMed ID: 20628005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.